Macter International Proposes 5-for-1 Share Split

Macter International Limited has suggested splitting each of its shares into five, lowering the face value from Rs. 10 to Rs. 2 per share. This modification aims to enhance market liquidity and make the stock more accessible to investors. The Board of Directors discussed the proposal on September 22 and it will be put before shareholders for approval at the next Annual General Meeting, pending necessary regulatory clearances.

Under the proposed plan, every current ordinary share valued at Rs. 10 will be exchanged for five ordinary shares worth Rs. 2. The company's overall issued, subscribed and paid-up capital will stay the same. Macter's share number will jump from 45,811,018 shares of Rs. 10 each to 229,055,090 shares of Rs. 2 each. Shareholders owning one Rs.

10 share at the effective date will receive five Rs. 2 shares under the proposed deal. The company explained the division is meant to boost market liquidity, make the stock more available to investors, and sync Macter's stock price with wider market participation. Macter International Limited is a Pakistani pharmaceutical firm founded in 1992.

Its shares have been trading on the Pakistan Stock Exchange since 2017. The company creates and sells pharmaceutical products in various dosage forms, such as tablets, capsules, syrups, injectables, creams and inhalers, and is a key contract manufacturer for overseas health firms.